摘要
Objective： The aim of the study was to investigate the expression and clinical significance of aldehyde dehydrogenase 1 （ALDH1） in breast cancer patients. Methods： The expression of ALDH1 protein was examined by immunohistochemical staining in 96 breast cancer tissues. The disease-free survival analysis of patients was evaluated based on the clinical follow-up data. Results： Expression of ALDH1 protein had significant correlations with ER, PR, and HER2 proteins （P 〈 0.05）, but had no significant correlations with age, tumor size, clinical stage, P-glycoprotein, and lymph node status （P 〉 0.05）. The 2-year disease-free survival rate of ALDHl-positive patients was lower than that of ALDHl-negative patients （P 〈 0.05）. ALDHl-positive patients undergoing chemotherapy and hormonal therapy had lower 2-year disease-free survival rate than ALDHl-negative patients （P 〈 0.05）. Conclusion： ALDH1 expression might play an important role in drug resistant, and ALDH1 may be used as a prognostic marker.
